Cargando…
Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255281/ https://www.ncbi.nlm.nih.gov/pubmed/35801229 http://dx.doi.org/10.2147/PTT.S380486 |
Ejemplares similares
-
Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management
por: Al-Janabi, A, et al.
Publicado: (2022) -
Annual biologic treatment cost for new and existing patients with
moderate to severe plaque psoriasis in Greece
[Corrigendum]
Publicado: (2015) -
Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]
Publicado: (2015) -
Literature Overview of the Relation Between Psoriasis and Alzheimer [Corrigendum]
Publicado: (2023) -
Continuous Wound Infiltration of Local Anesthetics in Postoperative Pain Management: Safety, Efficacy and Current Perspectives [Corrigendum]
Publicado: (2020)